2.7 Non-Mendelian Inheritance (Mitochondrial, Imprinting, Multifactorial)
Key Takeaways
- Mitochondrial DNA disorders are maternally transmitted; fathers with mtDNA disease generally do not pass mtDNA to offspring, while heteroplasmy and tissue thresholds drive variable severity
- Genomic imprinting is parent-of-origin silencing; the same 15q11.2-q13 region yields Prader-Willi or Angelman phenotypes depending on whether paternal or maternal contribution is missing
- Multifactorial traits reflect combined genetic liability and environmental exposures; the threshold model explains why recurrence rises with more affected relatives and greater severity
- Heritability estimates the proportion of population phenotypic variance attributable to genetic differences—it is not an individual’s percent chance of developing disease
- Non-Mendelian counseling fails when mitochondrial, imprinting, or multifactorial patterns are forced into 50%/25% single-gene scripts
2.7 Non-Mendelian Inheritance (Mitochondrial, Imprinting, Multifactorial)
Quick Answer: When pedigrees refuse Mendelian math, reach for three board frameworks: maternal mitochondrial (mtDNA) inheritance, genomic imprinting (parent-of-origin effects), and multifactorial/threshold disease with heritability as a population concept—not a personal probability.
These mechanisms appear across Domain 1 conditions and Domain 2 risk talks. Keep imprinting conceptual here; deep PWS/AS phenotype teaching belongs with chromosomal/imprinting syndrome chapters.
Mitochondrial Inheritance
Human mtDNA is transmitted through the oocyte. Clinical consequences:
| Principle | Counseling implication |
|---|---|
| Maternal transmission | A mother with a pathogenic mtDNA variant can transmit it to all children; a father with mtDNA disease typically does not transmit mtDNA disease to offspring |
| Heteroplasmy | Cells/tissues may carry a mixture of mutant and wild-type mtDNA |
| Threshold effect | Clinical disease often appears only when mutant load exceeds a tissue-specific threshold |
| Variable load | Heteroplasmy can differ among siblings and among tissues in one person → unpredictable severity |
| Bottleneck | A maternal bottleneck during oogenesis can shift heteroplasmy dramatically between generations |
Exam vignette cues: maternal lineage affected (mother, siblings, maternal aunts/uncles/cousins); no paternal transmission of the mtDNA trait; overlapping “mitochondrial” phenotypes (stroke-like episodes, myopathy, lactic acidosis, hearing loss, diabetes—pattern recognition, not a single pathognomonic list).
Nuclear vs mtDNA: Many mitochondrial diseases are caused by nuclear genes (Mendelian AR/AD/XL). Do not label every OXPHOS disorder “maternal inheritance.” Ask whether the variant is in mtDNA or nuclear DNA before quoting maternal-only transmission.
Practical counseling limits: Even with known maternal heteroplasmy, predicting a fetus’s load and phenotype is imprecise. Discuss reproductive options (including, where available and appropriate, mitochondrial replacement contexts as emerging/specialized topics) without overstating predictive precision of a single heteroplasmy percentage.
Genomic Imprinting (Parent-of-Origin Effects)
Imprinting means certain genes are expressed from only the maternal or only the paternal allele because of epigenetic marks established in gametogenesis.
| Concept | Board meaning |
|---|---|
| Parent-of-origin dependence | Deletion/UPD/epimutations matter based on which parent contributed the error |
| Same locus, different disease | Opposite phenotypes from loss of paternal vs maternal contribution |
| Not Mendelian segregation alone | Recurrence depends on mechanism (deletion vs UPD vs imprinting center vs single-gene), not a blanket 50% |
Clinical Link: Prader-Willi and Angelman (Mechanism Level)
Chromosome region 15q11.2-q13 is the classic teaching pair:
| Condition | Core genomic idea (keep brief) |
|---|---|
| Prader-Willi syndrome (PWS) | Lack of paternal contribution at the imprinted interval (paternal deletion, maternal uniparental disomy 15, or imprinting defect) |
| Angelman syndrome (AS) | Lack of functional maternal UBE3A contribution (maternal deletion, paternal UPD 15, imprinting defect, or maternal UBE3A pathogenic variant) |
Counseling point without duplicating syndrome depth: Mechanism determines recurrence. A de novo paternal deletion causing PWS has different recurrence implications than a familial imprinting-center variant or a maternal UBE3A variant causing AS. Always map parent of origin + molecular class before quoting numbers.
Other imprinting disorders (Beckwith-Wiedemann, Russell-Silver, and related growth syndromes) follow the same logic: phenotype tracks which parental allele is missing, duplicated, or epigenetically mis-set.
Multifactorial Inheritance and the Threshold Model
Multifactorial traits arise from combined polygenic liability plus environment (teratogens, nutrition, stochastic developmental noise, etc.). Congenital anomalies such as neural tube defects, cleft lip/palate, and many isolated heart defects are taught this way when not explained by a major Mendelian or chromosomal cause.
Threshold Model
Imagine a continuous liability distribution. Disease appears when liability crosses a threshold.
| Observation | Threshold-model explanation |
|---|---|
| Recurrence higher than population baseline after one affected child | Family shares elevated liability |
| Recurrence rises with ≥2 affected relatives | Greater shared genetic/environmental liability |
| More severe or bilateral defects → higher recurrence | More extreme liability in the family |
| Sex-differential thresholds | The less frequently affected sex may need higher liability to manifest → higher recurrence in relatives when the rare-sex proband is affected |
Empiric risks (published tables for specific anomalies) are used because single-locus Mendelian fractions do not apply. Quote condition-specific empiric figures; do not invent “25% multifactorial risk.”
Heritability at Board Level
Heritability (h²) estimates the fraction of phenotypic variance in a population attributable to genetic variance under a given environment. Critical clarifications:
| Heritability is | Heritability is not |
|---|---|
| A population statistic for a trait in a context | An individual’s percent chance of disease |
| Sensitive to environmental variation in the studied population | Proof that environment is unimportant when h² is high |
| Useful for understanding twin/family correlation patterns | A substitute for Mendelian counseling when a major gene is identified |
High heritability for height or schizophrenia-spectrum liability does not mean a counselor can tell one client “your risk is h².” For counseling, pair family history with empiric or Mendelian/genomic data appropriate to the case.
Side-by-Side: When to Leave Mendelian Scripts
| Clue in the case | Prefer this framework |
|---|---|
| Maternal-line mitochondrial features; no father-to-child mtDNA transmission | mtDNA inheritance + heteroplasmy/threshold |
| Opposite syndromes from 15q depending on parent of origin; UPD mentioned | Imprinting |
| Isolated common birth defect; mildly elevated sibling recurrence; no syndrome pattern | Multifactorial / empiric risks |
| Twin studies or “highly heritable” language without a gene | Heritability as population variance—not personal odds |
Session Structure
- Decide whether the pedigree fits Mendelian, mitochondrial, imprinting, or multifactorial first.
- For mtDNA, teach maternal transmission + heteroplasmy unpredictability without nuclear-gene confusion.
- For imprinting, name parent of origin and send mechanism-specific recurrence to the molecular result.
- For multifactorial anomalies, use threshold/empiric language and avoid forcing 50%/25%.
- Define heritability carefully if a stem uses the word—boards test misconceptions as often as definitions.
Non-Mendelian fluency prevents the most common Domain 2B error: applying autosomal recessive math to every “unaffected parents, affected child” vignette without checking mitochondria, imprinting, de novo dominant disease, or multifactorial liability.
A woman has a pathogenic mtDNA variant with variable heteroplasmy. Which statement is the most accurate reproductive counseling point?
A child has Angelman syndrome due to a maternal 15q11.2-q13 deletion. Which conceptual statement best explains why this is an imprinting-related diagnosis rather than simple autosomal recessive inheritance?
In multifactorial counseling for an isolated congenital anomaly, which statement correctly applies the threshold model?